Devika Ashok

Activated group 3 innate lymphoid cells promote T-cell–mediated immune responses

Nicole von Burg, Stéphane Chappaz, Anne Baerenwaldt et al. · Proceedings of the National Academy of Sciences · 2014 · 182 citations · Full text

Life Sciences, Cell Biology, Immunology +17

Novel Murine Dendritic Cell Lines: A Powerful Auxiliary Tool for Dendritic Cell Research

Silvia A. Fuertes Marraco, F. Grosjean, Anaïs Duval et al. · Frontiers in Immunology · 2012 · 172 citations · Full text

Life Sciences, Cell Biology, Immunology +9

Safety, tolerability, and pharmacology of AB928, a novel dual adenosine receptor antagonist, in a randomized, phase 1 study in healthy volunteers

Lisa Seitz, Lixia Jin, Manmohan R. Leleti et al. · Investigational New Drugs · 2018 · 64 citations

Medicine, Pharmacokinetics, Pharmacology +6

Cross‐presenting dendritic cells are required for control of <i><scp>L</scp>eishmania major</i> infection

Devika Ashok, Steffen Schuster, Catherine Ronet et al. · European Journal of Immunology · 2014 · 53 citations

Veterinary Medicine, Immunology, Pathology +17

AB928, a novel dual adenosine receptor antagonist, combined with chemotherapy or AB122 (anti-PD-1) in patients (pts) with advanced tumors: Preliminary results from ongoing phase I studies.

John D. Powderly, Paul L. de Souza, Rodolfo Gutierrez et al. · Journal of Clinical Oncology · 2019 · 32 citations

Medicine, Oncology, Pharmacology +17